Sep 30 |
QIAGEN launches QIAcuityDx digital PCR system for clinical testing in oncology
|
Sep 27 |
Those who invested in Qiagen (NYSE:QGEN) five years ago are up 41%
|
Sep 27 |
Qiagen secures EU IVDR certification for QIAstat-Dx systems and panels
|
Sep 27 |
QGEN Stock to Gain From New IVDR Win for QIAstat-Dx Systems and Panels
|
Sep 26 |
QIAGEN receives European IVDR certification for QIAstat-Dx syndromic testing instruments and assays
|
Sep 26 |
QIAGEN Stock Likely to Gain From PreAnalytiX's Newly Launched PAXgene
|
Sep 26 |
PreAnalytiX introduces urine liquid biopsy solution
|
Sep 25 |
PreAnalytiX, a QIAGEN and BD joint venture, launches novel solution for liquid biopsy from urine samples
|
Sep 24 |
QGEN Stock Might Rise on Partnership With Bode for GEDmatch PRO
|
Sep 23 |
QIAGEN and Bode Technology partner to advance use of GEDmatch PRO forensic genetic genealogy database
|